Renal Cell Carcinoma (RCC) Clinical Trials

Find Renal Cell Carcinoma (RCC) Clinical Trials Near You

A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The aim of this study is to evaluate the effect of two decision aids for renal cell carcinoma (RCC) on the decision-making process and the quality of the decision.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients clinically diagnosed with RCC

• Patients facing a decision which is addressed in the decision aids (T1 tumor or metastatic disease)

• Written informed consent

Locations
Other Locations
Netherlands
St. Antonius Ziekenhuis
RECRUITING
Nieuwegein
Contact Information
Primary
Cato Bresser
c.bresser@antoniusziekenhuis.nl
0631143301
Time Frame
Start Date: 2022-11-24
Estimated Completion Date: 2025-12
Participants
Target number of participants: 180
Treatments
Pre-test
Patients with RCC receiving usual care (without use of the decision aids)
Post-test
Patients with RCC using the decision aids
Related Therapeutic Areas
Sponsors
Collaborators: Merck Sharp & Dohme LLC
Leads: St. Antonius Hospital

This content was sourced from clinicaltrials.gov